Helen HOERZER
Inventor
Stats
- 1 US patents issued
- 40 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 40 US Applications Filed
- 35 Total Citation Count
- Jan 24, 2023 Most Recent Filing
- Jun 30, 2016 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
IMMATICS BIOTECHNOLOGIES GMBH | 13
1 | 2016
2017 |
Inventor Addresses
Address | Duration |
---|---|
US | Jul 20, 23 - Jul 20, 23 |
Tübingen, DE | Oct 25, 18 - Dec 03, 19 |
Tubingen, DE | Mar 08, 18 - Dec 06, 18 |
Tuebingen, DE | Jan 05, 17 - Feb 18, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 40 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 11 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12226466 | 2025 | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | 0 |
12071458 | 2024 | Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | 0 |
11912748 | 2024 | Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | 0 |
11912749 | 2024 | Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | 0 |
2023/0227,517 | 2023 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.